Compare Danaher Corporation (DHR) vs Lufax Holding Ltd (LU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Lufax Holding Ltd — how do they compare? Danaher Corporation trades at $200.05 (market cap $140.88B), while Lufax Holding Ltd trades at $1.35 (market cap $2.41B). The key difference: Danaher Corporation is far larger — about 58.5× Lufax Holding Ltd's market cap, and Danaher Corporation pays a 0.8% dividend while Lufax Holding Ltd pays none. Which is the better fit depends on your goals.
| DHR | LU | |
|---|---|---|
Market Cap | $140.88B | $2.41B |
Sector | Health | Technology |
52-Week High | $242.05 | $4.40 |
52-Week Low | $161.91 | $1.23 |
Enterprise Value | $153.66B | — |
Dividend Yield | 0.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
LU trades at $1.25, down 6.72% over 24 hours, with technical indicators signaling a bearish trend. The stock shows weak profitability with a -9.08% net margin and negative ROE of -2.6%, though valuation ratios like P/S of 0.33 and P/B of 0.1 appear low. Recent news highlights multiple class-action lawsuits filed against the company, alleging securities fraud between April 2023 and January 2025.
Outlook remains challenged by legal risks and poor earnings, but low valuations may attract speculative interest. Key risks include ongoing litigation and sustained unprofitability, while analyst consensus leans bullish with 62% buy ratings, suggesting potential recovery if operational improvements materialize.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Lufax Holding Ltd
Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →
